LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹525 Cr | ₹463 Cr | ₹391 Cr | ₹373 Cr | ₹328 Cr |
What is the latest Total Current Assets ratio of LINCOLN PHARMACEUTICALS ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹525 Cr |
| Mar2024 | ₹463 Cr |
| Mar2023 | ₹391 Cr |
| Mar2022 | ₹373 Cr |
| Mar2021 | ₹328 Cr |
How is Total Current Assets of LINCOLN PHARMACEUTICALS Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹525 Cr | 13.37 | |
| Mar2024 | ₹463 Cr | 18.37 | |
| Mar2023 | ₹391 Cr | 4.83 | |
| Mar2022 | ₹373 Cr | 13.85 | |
| Mar2021 | ₹328 Cr | - | |
Compare Total Current Assets of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹950.4 Cr | 0.9% | -10.2% | -47.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,768.0 Cr | -0.7% | 2% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,385.0 Cr | -2.1% | -2.8% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,242.0 Cr | -0.9% | -0.6% | 12.2% | Stock Analytics | |
| CIPLA | ₹121,093.0 Cr | -1% | -1.2% | 3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,799.0 Cr | -0.1% | 2.3% | 2.6% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 0.9% |
-10.2% |
-47.6% |
| SENSEX | -0.4% |
-0.2% |
2.9% |
You may also like the below Video Courses